LSA
FATE icon

Leonteq Securities AG’s Fate Therapeutics FATE Stock Holding History

Leonteq Securities AG’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51 Hold
19
– – ﹤0.01% 1257
2026
Q1 		$23 Hold
19
– – ﹤0.01% 1272
2025
Q4 		$19 Hold
19
– – ﹤0.01% 1424
2025
Q3 		$24 Hold
19
– – ﹤0.01% 1314
2025
Q2 		$21 Hold
19
– – ﹤0.01% 1257
2025
Q1 		$15 Hold
19
– – ﹤0.01% 1223
2024
Q4 		$31 Buy
+19
New +$48 ﹤0.01% 1245
2024
Q3 		– Sell
-1,325
Closed -$4.35K – 1229
2024
Q2 		$4.35K Hold
1,325
– – ﹤0.01% 1061
2024
Q1 		$9.73K Hold
1,325
– – ﹤0.01% 1015
2023
Q4 		$4.96K Buy
1,325
+730
+123% +$1.72K ﹤0.01% 1064
2023
Q3 		$1.26K Sell
595
-2
-0.3% -$7 ﹤0.01% 1144
2023
Q2 		$2.84K Sell
597
-881
-60% -$4.86K ﹤0.01% 1146
2023
Q1 		$8.43K Sell
1,478
-12,752
-90% -$76.9K ﹤0.01% 1052
2022
Q4 		$144K Buy
14,230
+7,556
+113% +$142K 0.01% 607
2022
Q3 		$150K Sell
6,674
-892
-12% -$25.8K 0.01% 579
2022
Q2 		$187K Buy
7,566
+2,985
+65% +$82.4K 0.01% 569
2022
Q1 		$178K Buy
4,581
+3,538
+339% +$137K 0.01% 616
2021
Q4 		$61K Buy
+1,043
New +$59.1K ﹤0.01% 865
2021
Q2 		– Sell
-400
Closed -$33K – 1086
2021
Q1 		$33K Sell
400
-3,583
-90% -$343K ﹤0.01% 827
2020
Q4 		$362K Buy
+3,983
New +$247K 0.02% 462

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Leonteq Securities AG's FATE Position: Q2 2026 in Review

Leonteq Securities AG held its Fate Therapeutics (FATE) position steady in Q2 2026 at 19 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Leonteq Securities AG first reported a position in FATE in Q4 2020 and has held it in 20 quarters since. The position peaked at $362K in Q4 2020. 155 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Leonteq Securities AG held 19 shares of Fate Therapeutics worth $51 as of Q2 2026.
  • Leonteq Securities AG left its Fate Therapeutics share count unchanged in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1257 holding.
  • Leonteq Securities AG first reported a position in Fate Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Leonteq Securities AG's Fate Therapeutics position peaked at $362K in Q4 2020.
  • 155 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.